The regulation of ATF3 gene expression by mitogen-activated protein kinases

Biochemical Journal

Volumn 401, Issue 2, 2007, Pages 559-567

  Lu, Dan ^a   Chen, Jingchun ^a   Hai, Tsonwin ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Activating transcription factor 3 (ATF3); MAPK kinase (MKK); Mitogen activated protein kinase (MAPK); p38; Stress kinase; Stress response

Indexed keywords

CELLS; ENZYME INHIBITION; ENZYMES; STRESS ANALYSIS; TUMORS;

ACTIVATING TRANSCRIPTION FACTOR 3 (ATF3); MAPK KINASE (MKK); MITOGEN ACTIVATED PROTEIN KINASE (MAPK); STRESS KINASE; STRESS RESPONSE;

GENETIC ENGINEERING;

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVATING TRANSCRIPTION FACTOR 3; ANISOMYCIN; CASPASE 3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL DETECTION;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; ANISOMYCIN; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; ENZYME INDUCTION; FLAVONOIDS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 7; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; TRANSCRIPTION FACTORS;

EID: 33846551201     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20061081     Document Type: Article

References (53)

1. Hai, T., Wolfgang, C. D., Marsee, D. K., Allen, A. E. and Sivaprasad, U. (1999) ATF3 and stress responses. Gene Expr. 7, 321-335
2. Hai, T. and Hartman, M. G. (2001) The molecular biology and nomenclature of the ATF/CREB family of transcription factors' ATF proteins and homeostasis. Gene 273, 1-11
3. Hai, T. (2006) The ATF transcription factors in cellular adaptive responses. In Gene Expression and Regulation, a Current Scientific Frontiers Book (Ma, J., ed.). pp. 322-333, Higher Education Press, Beijing, People's Republic of China and Springer-Verlag, New York
4. Chen, B. P. C., Wolfgang, C. D. and Hai, T. (1996) Analysis of ATF3: a transcription factor induced by physiological stresses and modulated by gadd153/Chop10. Mol. Cell. Biol. 16, 1157-1168
5. Hartman, M. G., Lu, D., Kim, M. L., Kociba, G. J., Shukri, T., Buteau, J., Wang, X., Frankel, W. L., Guttridge, D., Prentki, M et al. (2004) Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol. Cell. Biol. 24, 5721-5732
6. 2-terminal kinase and promoter response element. Blood 96, 2140-2148
7. Iyengar, P., Combs, T. P., Shah, S. J., Gouon-Evans, V., Pollard, J. W., Albanese, C., Flanagan, L., Tenniswood, M. P., Guha, C., Lisanti, M. P. et al. (2003) Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 22, 6408-6423
8. Cho, R. J., Huang, M., Campbell, M. J., Dong, H., Steinmetz, L., Sapinoso, L. Hampton, G., Elledge, S. J., Davis, R. W. and Lockhart, D. J. (2001) Transcriptional regulation and function during the human cell cycle. Nat. Genet. 27, 48-54
9. van der Meijden, C. M., Lapointe, D. S., Luong, M. X., Peric-Hupkes, D., Cho, B., Stein, J. L., van Wijnen, A. J. and Stein, G. S. (2002) Gene profiling of cell cycle progression through S-phase reveals sequential expression of genes required for DNA replication and nucleosome assembly. Cancer Res. 62, 3233-3243
10. Ross-Macdonald, P., Coelho, P. S., Roemer, T., Agarwal, S., Kumar, A., Jansen, R., Cheung, K. H., Sheehan, A., Symoniatis, D., Umansky, L. et al. (1999) Large-scale analysis of the yeast genome by transposon tagging and gene disruption. Nature 402, 413-418
11. Cowan, K. J. and Storey, K. B. (2003) Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J. Exp. Biol. 206, 1107-1115
12. Whitmarsh, A. J. and Davis, R. J. (1999) Signal transaction by MAP kinases: regulation by phosphorylation-dependent switches. Science STKE 1999, PE1
13. Chang, L. and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37-40
14. Liang, G., Wolfgang, C. D., Chen, B. P. C., Chen, T. H. and Hai, T. (1996) ATF3 gene: genome organization, promoter and regulation. J. Biol. Chem. 271, 1695-1701
15. Derijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M. and Davis, R. J. (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037
16. Gupta, S., Campbell, D., Derijard, B. and Davis, R. J. (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389-393
17. Kallunki, T, Su, B., Tsigelny, I., Sluss, H. K., Derijard, B., Moore, G., Davis, R. J. and Karin, M. (1994) JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8, 2996-3007
18. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J. and Woodgett, J. R. (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160
19. Morrison, D. K. and Davis, R. J. (2003) Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19, 91-118
20. Zanke, B. W., Elizabeth, A. R., Winnet, E., Chan, J., Randall, S., Parsons, M., Bordreau, K., Mclnnis, M., Yan, M., Templeton, D. et al. (1996) Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes. J. Biol. Chem. 271, 29876-29881
21. Lu, D., Wolfgang, C. D. and Hal, T. (2006) ATF3: a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. J. Biol. Chem. 281, 10473-10481
22. Bonny, C., Oberson, A., Negri, S., Sauser, C. and Schorderet, D. F. (2001) Cell-permeable peptide inhibitors of JNK. Diabetes 50, 77-52
23. Southgate, T. D., Kingston, P. A. and Castro, M. G. (2000) Gene transfer into neural cells in vitro using adenoviral vectors. In Current Protocols in Neuroscience, pp. 4.23.21-24.23.40, John Wiley and Sons, New York
24. Allen-Jennings, A. E., Hartman, M. G., Kociba, G. J. and Hai, T. (2001) The roles of ATF3 in glucose homeostasis: a transgenic mouse model with liver dysfunction and defects in endocrine pancreas. J. Biol. Chem. 276, 29507-29514
25. Cano, E., Hazzalin, C. A. and Mahadevan, L. C. (1994) Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol. Cell. Biol. 14, 7352-7362
26. Cano and Mahadevan (1995) Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20, 117-122
27. Nahas, N., Molski, T. F., Fernandez, G. A. and Sha'afi, R. I. (1996) Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. Biochem. J. 318, 247-253
28. Dhawan, P., Bell, A., Kumar, A., Golden, C. and Mehta, K. D. (1999) Critical role of p42/44(MAPK) activation in anisomycin and hepatocyte growth factor-induced LDL receptor expression: activation of Raf-1/Mek-1/p42/44(MAPK) cascade alone is sufficient to induce LDL receptor expression. J. Lipid Res. 40, 1911-1919
29. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J. and Saltiel, A. R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U.S.A. 92, 7686-7689
30. Robinson, M. J., Stippec, S. A., Goldsmith, E., White, M. A. and Cobb, M. H. (1998) A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8, 1141-1150
31. Schwarze, S. R., Ho, A., Vocero-Akbani, A. and Dowdy, S. F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572
32. 2-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 94, 7337-7342
33. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R. and Lee, J. C. (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-233
34. Clerk, A. and Sugden, P. H. (1998) The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett. 426, 93-96
35. Bottone, Jr, F. G., Moon, Y., Alston-Mills, B. and Eling, T. E. (2005) Transcriptional regulation of activating transcription factor 3 involves the early growth response-1 gene. J. Pharmacol. Exp. Ther. 315, 668-677
36. Lindwall, C., Dahlin, L., Lundborg, G. and Kanje, M. (2004) Inhibition of c-Jun phosphorylation reduces axonal outgrowth of adult rat nodose ganglia and dorsal root ganglia sensory neurons. Mol. Cell. Neurosci. 27, 267-279
37. Kool, J., Hamdi, M., Cornelissen-Steijger, P., van der Eb, A. J., Terleth, C. and van Dam, H. (2003) Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAP kinases and ATF-2. Oncogene 22, 4235-4242
38. Inoue, K., Zama, T., Kamimoto, T., Aoki, R., Ikeda, Y., Kimura, H. and Hagiwara, M. (2004) TNFalpha-induced ATF3 expression is bidirectionally regulated by the JNK and ERK pathways in vascular endothelial cells. Genes Cells 9, 59-70
39. Lipson, K. E. and Baserga, R. (1989) Transcriptional activity of the human thymidine kinase gene determined by a method using the polymerase chain reaction and an intron-specific probe. Proc. Natl. Acad. Sci. U.S.A. 86, 9774-9777
40. Shi, Y. and Gaestel, M. (2002) In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol. Chem. 383, 1519-1536
41. Ahn, S., Olive, M., Aggarwal, S., Krylov, D., Ginty, D. D. and Vinson, C. (1998) A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol. Cell. Biol. 18, 967-977
42. Molkentin, J. D., Black, B. L., Martin, J. F. and Olson, E. N. (1996) Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol. Cell. Biol. 16, 2627-2636
43. Martin, J. F., Schwarz, J. J. and Olson, E. N. (1993) Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc. Natl. Acad. Sci. U.S.A. 90, 5282-5286
44. Kang, Y., Chen, C. R. and Massague, J. (2003) A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11, 915-926
45. Zhang, C., Gao, C., Kawauchi, J., Hashimoto, Y., Tsuchida, N. and Kitajima, S. (2002) Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53. Biochem. Biophys. Res. Commun. 297, 1302-1310
46. Huo, J. S., McEachin, R. C., Cui, T. X., Duggal, N. K., Hai, T., States, D. J. and Schwartz, J. (2006) Profiles of growth hormone (GH)-regulated genes reveal time-dependent responses and identify a mechanism for regulation of activating transcription factor 3 by GH. J. Biol. Chem. 281, 4132-4141
47. Wada, T. and Penninger, J. M. (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23, 2838-2849
48. Nawa, T., Nawa, M. T., Adachi, M. T., Uchimura, I., Shimokawa, R., Fujisawa, K., Tanaka, A., Numano, F. and Kitajima, S. (2002) Expression of transcriptional repressor ATF3/LRF1 in human atherosclerosis: colocalization and possible involvement in cell death of vascular endothelial cells. Atherosclerosis 161, 281-291
49. Yan, C., Jamaluddin, M. S., Aggarwal, B., Myers, J. and Boyd, D. D. (2005) Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol. Cancer Ther. 4, 233-241
50. Yamaguchi, K., Lee, S. H., Kim, J. S., Wimalasena, J., Kitajima, S. and Baek, S. J. (2006) Activating transcription factor 3 and early growth response 1 are the novel targets of LY294002 in a phosphatidylinositol 3-kinase-independent pathway. Cancer Res. 66, 2376-2384
51. Olson, J. M. and Hallaban, A. R. (2004) p38 MAP kinase: a convergence point in cancer therapy. Trends Mol. Med. 10, 125-129
52. Herrera, B., Carracedo, A., Diez-Zaera, M., Guzman, M. and Velasco, G. (2005) p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells. FEBS Lett. 579, 5084-5088
53. Ahn, Y. H., Jung, J. M. and Hong, S. H. (2005) 8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells. Cancer Res. 65, 4896-4901